EVALUATION OF THE INFLAMMATORY INFILTRATE IN POUCHITIS WITH IN-111 LABELED GRANULOCYTES

被引:46
作者
KMIOT, WA
HESSLEWOOD, SR
SMITH, N
THOMPSON, H
HARDING, LK
KEIGHLEY, MRB
机构
[1] QUEEN ELIZABETH HOSP,DEPT SURG,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND
[2] DUDLEY RD GEN HOSP,DEPT NUCL MED,BIRMINGHAM B18 7QH,W MIDLANDS,ENGLAND
[3] GEN HOSP,DEPT HISTOPATHOL,BIRMINGHAM B4 6NH,W MIDLANDS,ENGLAND
关键词
D O I
10.1016/0016-5085(93)90264-D
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The aim of this study was to elucidate the inflammatory infiltrate in pouchitis and define the changes following metronidazole therapy. Methods: Twenty-seven patients underwent functional grading, sigmoidoscopic and histological scoring, 111In-labeled granulocyte scanning, and 4-day fecal collections for 111In-labeled granulocyte excretion. Six of the patients with pouchitis underwent repeat studies after 1-month treatment with metronidazole, 400 mg three times daily. Results: The grade of macroscopic inflammation in the pouch mucosa (sigmoidoscopic score) correlated well with the acute histological score (P <0.0001), chronic histological score (P < 0.001), 4-hour 111In scan (P < 0.001), 24-hour 111In scan (P < 0.001), and with 4-day fecal 111In excretion (P < 0.001). After metronidazole therapy there was decreased inflammatory grade sigmoidoscopically and histologically on the 4- and 24-hour scans and decreased 4-day fecal 111In granulocyte excretion. Conclusions: This study confirms that the inflammatory infiltrate in pouchitis is acute or chronic, is characterized by neutrophils, is usually localized to pouch mucosa, and is always decreased after metronidazole therapy. © 1993.
引用
收藏
页码:981 / 988
页数:8
相关论文
共 32 条
[1]   VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS [J].
BARON, JH ;
CONNELL, AM ;
LENNARDJONES, JE .
BRITISH MEDICAL JOURNAL, 1964, 1 (5374) :89-+
[2]   RADIOLABELED GRANULOCYTES IN INFLAMMATORY BOWEL-DISEASE - DIAGNOSTIC POSSIBILITIES AND CLINICAL INDICATIONS [J].
BECKER, W ;
FISCHBACH, W ;
WEPPLER, M ;
MOSL, B ;
JACOBY, G ;
BORNER, W .
NUCLEAR MEDICINE COMMUNICATIONS, 1988, 9 (10) :693-701
[3]   THE PREPARATION AND INVIVO BEHAVIOR OF IN-111 OXINE LABELED NEUTROPHILS SEPARATED FROM WHOLE-BLOOD USING MONO-POLY RESOLVING MEDIUM [J].
BELL, D ;
MILLAR, AM ;
MCGILLIVRAY, M ;
MUIR, AL .
NUCLEAR MEDICINE COMMUNICATIONS, 1986, 7 (06) :447-453
[4]  
BLAND M, 1987, INTRO MED STATISTICS, P151
[5]   EVALUATION OF INDIUM SCINTIGRAPHY IN PATIENTS WITH ACTIVE INFLAMMATORY BOWEL-DISEASE [J].
BUXTONTHOMAS, MS ;
DICKINSON, RJ ;
MALTBY, P ;
HUNTER, JO ;
WRAIGHT, EP .
GUT, 1984, 25 (12) :1372-1375
[6]   CONTROLLED TRIAL OF INTRAVENOUS METRONIDAZOLE AS AN ADJUNCT TO CORTICOSTEROIDS IN SEVERE ULCERATIVE-COLITIS [J].
CHAPMAN, RW ;
SELBY, WS ;
JEWELL, DP .
GUT, 1986, 27 (10) :1210-1212
[7]  
DATZ FL, 1985, J NUCL MED, V26, P469
[8]   METRONIDAZOLE IN TREATMENT OF CHRONIC PROCTITIS - CONTROLLED TRIAL [J].
DAVIES, PS ;
RHODES, J ;
HEATLEY, RV ;
OWEN, E .
GUT, 1977, 18 (08) :680-681
[9]   SINGLE-STEP SEPARATION OF RED BLOOD-CELLS, GRANULOCYTES AND MONONUCLEAR LEUKOCYTES ON DISCONTINUOUS DENSITY GRADIENTS OF FICOLL-HYPAQUE [J].
ENGLISH, D ;
ANDERSEN, BR .
JOURNAL OF IMMUNOLOGICAL METHODS, 1974, 5 (03) :249-252
[10]   A COMPARATIVE-STUDY OF METRONIDAZOLE AND SULFASALAZINE IN ACTIVE, NOT SEVERE, ULCERATIVE-COLITIS - AN ISRAELI MULTICENTER TRIAL [J].
GILAT, T ;
SUISSA, A ;
LEICHTMAN, G ;
DELPRE, G ;
PAVLOTZKY, M ;
GROSSMAN, A ;
FIREMAN, Z .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1987, 9 (04) :415-417